Dr. Michael Leonardi, MD

NPI: 1932295425
Total Payments
$5,631
2024 Payments
$53.38
Companies
7
Transactions
22

Payment Breakdown by Category

Research$3,935 (69.9%)
Consulting$1,423 (25.3%)
Food & Beverage$273.99 (4.9%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $3,935 3 69.9%
Consulting Fee $1,423 2 25.3%
Food and Beverage $273.99 17 4.9%

Payments by Type

Research
$3,935
3 transactions
General
$1,696
19 transactions

Top Paying Companies

Company Total Records Latest Year
GlaxoSmithKline, LLC. $5,357 5 $0 (2020)
PFIZER INC. $86.27 7 $0 (2019)
Shire North American Group Inc $80.27 5 $0 (2018)
NeurAxis, Inc. $53.38 1 $0 (2024)
Ironshore Pharmaceuticals Inc. $25.08 2 $0 (2020)
Sobi, Inc $18.05 1 $0 (2021)
SANOFI PASTEUR INC. $10.94 1 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $53.38 1 NeurAxis, Inc. ($53.38)
2021 $18.05 1 Sobi, Inc ($18.05)
2020 $888.89 2 GlaxoSmithKline, LLC. ($875.00)
2019 $25.81 3 Ironshore Pharmaceuticals Inc. ($11.19)
2018 $1,293 9 GlaxoSmithKline, LLC. ($1,188)
2017 $3,352 6 GlaxoSmithKline, LLC. ($3,294)

All Payment Transactions

22 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
03/20/2024 NeurAxis, Inc. Food and Beverage Cash or cash equivalent $53.38 General
04/15/2021 Sobi, Inc SYNAGIS (Drug) Food and Beverage In-kind items and services $18.05 General
Category: IMMUNOLOGY
03/02/2020 GlaxoSmithKline, LLC. Consulting Fee Cash or cash equivalent $875.00 General
02/14/2020 Ironshore Pharmaceuticals Inc. JORNAY PM (Drug) Food and Beverage In-kind items and services $13.89 General
Category: Central Nervous Stimulant ADHD
07/09/2019 SANOFI PASTEUR INC. MENACTRA (Drug), ADACEL, FLUZONE QUADRIVALENT Food and Beverage In-kind items and services $10.94 General
Category: VACCINES
07/02/2019 Ironshore Pharmaceuticals Inc. Jornay PM 20mg capsules (Bottle of 100) (Drug) Food and Beverage In-kind items and services $11.19 General
Category: Central nervous system (CNS) stimulant
01/18/2019 PFIZER INC. PREVNAR - 13 (Biological), TRUMENBA Food and Beverage In-kind items and services $3.68 General
Category: VACCINES
11/08/2018 PFIZER INC. PREVNAR - 13 (Biological), TRUMENBA Food and Beverage In-kind items and services $14.92 General
Category: VACCINES
09/19/2018 PFIZER INC. EUCRISA (Drug) Food and Beverage In-kind items and services $13.61 General
Category: DERMATOLOGY
08/01/2018 Shire North American Group Inc VYVANSE (Drug) Food and Beverage In-kind items and services $14.48 General
Category: NEUROSCIENCE
07/17/2018 Shire North American Group Inc VYVANSE (Drug) Food and Beverage In-kind items and services $13.46 General
Category: NEUROSCIENCE
06/30/2018 GlaxoSmithKline, LLC. In-kind items and services $640.84 Research
Study: MMR-162
06/13/2018 Shire North American Group Inc VYVANSE (Drug) Food and Beverage In-kind items and services $24.32 General
Category: NEUROSCIENCE
05/15/2018 PFIZER INC. PREVNAR - 13 (Biological), TRUMENBA Food and Beverage In-kind items and services $20.35 General
Category: VACCINES
02/01/2018 GlaxoSmithKline, LLC. Consulting Fee Cash or cash equivalent $547.50 General
01/09/2018 PFIZER INC. PREVNAR - 13 (Biological), TRUMENBA Food and Beverage In-kind items and services $3.80 General
Category: VACCINES
10/03/2017 Shire North American Group Inc MYDAYIS (Drug) Food and Beverage In-kind items and services $17.51 General
Category: NEUROSCIENCE
05/31/2017 GlaxoSmithKline, LLC. Cash or cash equivalent $2,371.14 Research
Study: MMR 157 PRI
05/31/2017 GlaxoSmithKline, LLC. Cash or cash equivalent $922.78 Research
Study: HIB 097
04/24/2017 PFIZER INC. EUCRISA (Drug) Food and Beverage In-kind items and services $13.90 General
Category: DERMATOLOGY
04/19/2017 Shire North American Group Inc VYVANSE (Drug) Food and Beverage In-kind items and services $10.50 General
Category: NEUROSCIENCE
02/13/2017 PFIZER INC. PREVNAR - 13 (Biological) Food and Beverage In-kind items and services $16.01 General
Category: VACCINES

Research Studies & Clinical Trials

Study Name Company Amount Records
MMR 157 PRI GlaxoSmithKline, LLC. $2,371 1
HIB 097 GlaxoSmithKline, LLC. $922.78 1
MMR-162 GlaxoSmithKline, LLC. $640.84 1

About Dr. Michael Leonardi, MD

Dr. Michael Leonardi, MD is a Pediatrics healthcare provider based in Charleston, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1932295425.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Leonardi, MD has received a total of $5,631 in payments from pharmaceutical and medical device companies, with $53.38 received in 2024. These payments were reported across 22 transactions from 7 companies. The most common payment nature is "" ($3,935).

Practice Information

  • Specialty Pediatrics
  • Location Charleston, SC
  • Active Since 10/04/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 208000000X
  • Entity Type Individual
  • NPI Number 1932295425

Products in Payments

  • VYVANSE (Drug) $62.76
  • PREVNAR - 13 (Biological) $58.76
  • EUCRISA (Drug) $27.51
  • SYNAGIS (Drug) $18.05
  • MYDAYIS (Drug) $17.51
  • JORNAY PM (Drug) $13.89
  • Jornay PM 20mg capsules (Bottle of 100) (Drug) $11.19
  • MENACTRA (Drug) $10.94

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatrics Doctors in Charleston